Ignite Creation Date:
2025-12-25 @ 3:07 AM
Ignite Modification Date:
2025-12-31 @ 11:53 PM
Study NCT ID:
NCT05259033
Status:
COMPLETED
Last Update Posted:
2025-07-09
First Post:
2022-02-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-11
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-16
Completion Date Type:
ACTUAL
First Submit Date:
2022-02-10
First Submit QC Date:
None
Study First Post Date:
2022-02-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-12-11
Results First Submit QC Date:
None
Results First Post Date:
2025-01-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-08
Last Update Post Date:
2025-07-09
Last Update Post Date Type:
ACTUAL